BCICX | FFNAX | BCICX / FFNAX | |
Total Expense Ratio | 1.57 | 0.78 | 201% |
Annual Report Gross Expense Ratio | 1.69 | 0.78 | 217% |
Fund Existence | 17 years | 18 years | - |
Gain YTD | 6.531 | 7.133 | 92% |
Front Load | N/A | 6% | - |
Min. Initial Investment | 1000 | 0 | - |
Min. Initial Investment IRA | 100 | 500 | 20% |
Net Assets | 10.5B | 2.3B | 456% |
Annual Yield % from dividends | 4.92 | 2.34 | 210% |
Returns for 1 year | 9.21 | 9.91 | 93% |
Returns for 3 years | 23.39 | 21.16 | 111% |
Returns for 5 years | 22.47 | 22.85 | 98% |
Returns for 10 years | 43.36 | 46.14 | 94% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
SHPAX | 19.36 | 0.10 | +0.52% |
Saratoga Health & Biotechnology A | |||
BHSRX | 56.23 | 0.28 | +0.50% |
BlackRock Health Sciences Opps R | |||
TLAFX | 12.11 | 0.04 | +0.33% |
Transamerica Large Core ESG R4 | |||
SWDSX | 17.39 | 0.05 | +0.29% |
Schwab Dividend Equity | |||
NSEPX | 22.92 | 0.06 | +0.26% |
Columbia Select Large Cap Equity Inst |